Hans Wildiers: Department of General medical oncology, University Hospitals Leuven, Leuven, Belgium

Hans Wildiers is a medical oncologist dedicated to breast cancer research and geriatric oncology. He is staff member at the department of medical oncology in the University Hospital Leuven, Belgium since 2004. He coordinates the Leuven multidisciplinary breast center since 2015. He has been coordinator of several academic studies in the field of breast cancer and geriatric oncology, and author of more than 200 peer reviewed papers. He has been active within the board of SIOG, the International Society of Geriatric Oncology, for many years, and serves this organisation as President from November 2018 till October 2020. From 2009 till 2015, he has chaired the elderly task force cancer of the elderly of the European Organisation for Research and Treatment of Cancer (EORTC).

SIOG presidential session and SIOG 2018 awards

2018-08-07T15:17:00+02:00

Chairs: Stuart Lichtman (US), Hans Wildiers (BE)11:30-11:45 - Presidential Address - Hans Wildiers (BE)11:45-12:00 - SIOG CEO Address - Najia Musolino (CH)12:00-12:10 - SIOG 2018 Calabresi award presentation - Martine Puts (CA)12:10-12:30 - SIOG 2018 Awards - Stuart Lichtman (US) and Hans Wildiers (BE)SIOG 2018 Nursing & Allied Health Investigator awardSIOG 2018 Young Investigator awardSIOG 2018 Young Research PrizeSIOG 2018 Best Poster award

SIOG presidential session and SIOG 2018 awards2018-08-07T15:17:00+02:00

Plenary session: Geriatric oncology – How research should influence clinical care and future research

2018-08-07T15:09:00+02:00

Chairs: Etienne Brain (FR), Hans Wildiers (BE) 08:00-08:25 - The best of the Journal of Geriatric Oncology - Supriya Mohile (US) & Siri Rostoft (NO)08:25-08:50 - From another perspective - EHA - Dominique Bron (FR)08:50-09:00 - Discussion and questions

Plenary session: Geriatric oncology – How research should influence clinical care and future research2018-08-07T15:09:00+02:00

With progress comes controversy: discussion on the dilution vs dispersion of geriatric assessment

2018-08-07T12:23:00+02:00

Chairs: Tanya Wildes (US), Hans Wildiers (BE)Panellists: Marije Hamaker (NL), Cindy Kenis (BE), Siri Rostoft (NO), Enrique Soto Perez de Celis (MX)16:15-16:30 - Indiscriminant use of CGA in oncology is diluting its utility and value - Martine Puts (CA)16:30-16:45 - Panel discussion16:45 -17:00 - Counterpoint:  use of the CGA is pivotal to disseminating the principles of geriatrics into the care of older adults with cancer - Heidi Klepin (US)17:00-17:15 - Panel discussion17:15-17:45 - Audience interaction

With progress comes controversy: discussion on the dilution vs dispersion of geriatric assessment2018-08-07T12:23:00+02:00
Go to Top